Success Metrics

Clinical Success Rate
84.8%

Based on 78 completed trials

Completion Rate
85%(78/92)
Active Trials
44(26%)
Results Posted
12%(9 trials)
Terminated
14(8%)

Phase Distribution

Ph early_phase_1
2
1%
Ph phase_1
5
3%
Ph phase_2
2
1%
Ph phase_3
1
1%
Ph not_applicable
48
28%
Ph phase_4
1
1%

Phase Distribution

7

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution59 total trials
Early Phase 1First-in-human
2(3.4%)
Phase 1Safety & dosage
5(8.5%)
Phase 2Efficacy & side effects
2(3.4%)
Phase 3Large-scale testing
1(1.7%)
Phase 4Post-market surveillance
1(1.7%)
N/ANon-phased studies
48(81.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.2%

78 of 101 finished

Non-Completion Rate

22.8%

23 ended early

Currently Active

44

trials recruiting

Total Trials

169

all time

Status Distribution
Active(51)
Completed(78)
Terminated(23)
Other(17)

Detailed Status

Completed78
Recruiting34
unknown17
Terminated14
Active, not recruiting10
Withdrawn9

Development Timeline

Analytics

Development Status

Total Trials
169
Active
44
Success Rate
84.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.4%)
Phase 15 (8.5%)
Phase 22 (3.4%)
Phase 31 (1.7%)
Phase 41 (1.7%)
N/A48 (81.4%)

Trials by Status

withdrawn95%
unknown1710%
active_not_recruiting106%
terminated148%
completed7846%
enrolling_by_invitation21%
not_yet_recruiting53%
recruiting3420%

Recent Activity

Clinical Trials (169)

Showing 20 of 169 trialsScroll for more
NCT01060371

Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias

Recruiting
NCT07664891

Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma

Recruiting
NCT04852731Not Applicable

STretch and Myocardial Characterization in Arrythmogenic Mitral Valve Prolapse-2

Active Not Recruiting
NCT03307408

Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease

Completed
NCT05053932

Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia

Completed
NCT02382601

Longitudinal Study of Intra-Uterine Growth Restriction

Recruiting
NCT05324553

Patient Derived Preclinical Models

Recruiting
NCT05540561

Biological Diagnosis and Monitoring of Chronic Nitrous Oxide Abuse

Recruiting
NCT06195150

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

Active Not Recruiting
NCT07075107Not Applicable

Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases

Recruiting
NCT04680117Not Applicable

Defining the Severe Paediatric Asthma Endotype

Completed
NCT07566780

Cell-based Non-invasive Prenatal Test Workflow

Not Yet Recruiting
NCT04451980

The HIV, Adipose Tissue Immunology, and Metabolism Study

Completed
NCT06074133

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

Active Not Recruiting
NCT05051722

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Recruiting
NCT03776474

Determine Immunoglobulin G4 (IgG4) Standards for Cow's Milk and Egg in Different Populations of Allergic and Non-allergic Children

Completed
NCT04703114Not Applicable

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)

Completed
NCT05847855

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

Recruiting
NCT07134491

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Recruiting
NCT05716022

Hiatal Hernia and Pulmonary Involvement

Completed

Drug Details

Intervention Type
OTHER
Total Trials
169